J. Gormley

发表

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity

J. Johnston, H. Kwok, A. Kissenpfennig, 2011, Molecular Cancer.

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF

J. Johnston, C. Scott, Diana Kuehn, 2010, PloS one.

Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas.

J. Johnston, H. Kwok, C. Scott, 2012, Biochimie.

Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.

E. Raymond, M. D’Incalci, R. Frapolli, 2015, Biochimie.

A Novel High-Throughput Technique for Identifying Monoclonal Antibodies Capable of Death Receptor Induced Apoptosis

J. Johnston, H. Kwok, C. Scott, 2009, Journal of cell death.

Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis

J. Johnston, B. Walker, C. Scott, 2009, Clinical Cancer Research.

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study

J. Johnston, E. Kay, P. Johnston, 2011, British Journal of Cancer.

Enhanced Antitumor Activity of the Photosensitizer meso-Tetra(N-methyl-4-pyridyl) Porphine Tetra Tosylate through Encapsulation in Antibody-Targeted Chitosan/Alginate Nanoparticles

J. F. Burrows, D. Longley, D. Schmid, 2013, Biomacromolecules.

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

L. Ouafik, O. Touzelet, M. Riveiro, 2021, Frontiers in Oncology.

Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.

E. Raymond, M. D’Incalci, R. Frapolli, 2015, Biochimie.